Latest Close
$2.09
News
ACXP
Acurx Pharmaceuticals, Inc. News
This news view pulls recent coverage and headlines tied to ACXP.
1y Change
-$5.11 (-70.97%)
Market Cap
$5,967,002.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
strong_buy
Acurx Announces Scientific Poster Presentation of its DNA pol IIIC Inhibitors' Microbiome Evaluation at ESCMID Global 2026
PR Newswire • May 4, 2026
Read articleAcurx Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
PR Newswire • Apr 29, 2026
Read articleAcurx Pharmaceuticals, Inc. To Present at The Market Movers Investor Summit
TMX Newsfile • Apr 27, 2026
Read articleAcurx Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 12, 2026 Conference Call and Provide Business Update
PR Newswire • Apr 20, 2026
Read articleNew to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Group Holding (NASDAQ:YYGH), and Vivos Therapeutics (NASDAQ:VVOS)
ACCESS Newswire • Apr 18, 2026
Read articleAcurx Pharmaceuticals, Inc. Announces Closing of up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
PR Newswire • Apr 16, 2026
Read article